Pathophysiology and Treatment of Atherosclerotic Disease in Peripheral Arteries is a thorough review of the disease written by experts studying its detection and treatment. These state-of-the-art chapters summarize emerging knowledge about this important area of medicine. The pathophysiology and treatment of peripheral artery (PAD) disease remains poorly understood even by practitioners. Often it is assumed that PAD should be treated in a similar fashion to coronary artery disease (CAD), when in fact recent data suggest a distinct pathophysiology with genetic risk having some but not complete overlap with CAD. This is a novel reference of emerging data on the factors behind its development and progression, detection, and treatment suggest an emerging paradigm for this disease.
Les mer
1. Introduction 2. Atherosclerosis- pathology of lower extremity atherosclerosis 3. Epidemiology of PAD 4. Molecular Understanding of Peripheral Arterial Disease 5. Non-invasive imaging of CT and MRA in Evaluation of PAD 6. Medical Therapy of PAD: Joshua Beckman 7. Intravascular Imaging: Role in PAD 8. Interventional Treatment of PAD: Atherectomy 9. Interventional Treatment of PAD: Drug Coated Balloons and Stents 10. Future Directions
Les mer
A review of the pathophysiology of lower extremity atherosclerosis for current and future medical and interventional treatments
Provides understanding for the pathophysiology of PAD from pathologic and molecular perspectives Reviews state-of-the art modalities for its detection as well as the data surrounding new medical and interventional treatment for PAD Elucidates the impact of new treatment modalities such as drug coated balloons and atherectomy devices such a lithotripsy
Les mer

Produktdetaljer

ISBN
9780443135934
Publisert
2024-06-14
Utgiver
Vendor
Elsevier - Health Sciences Division
Vekt
530 gr
Høyde
235 mm
Bredde
191 mm
Aldersnivå
P, 06
Språk
Product language
Engelsk
Format
Product format
Heftet
Antall sider
252

Om bidragsyterne

Dr. Aloke Virmani Finn is a physician-scientist whose focus is on the pathology of cardiovascular disease and its treatment.?He serves as the Medical Director and Chief Scientific Officer for CVPath Institute where he oversees device development research and runs a molecular lab with focus on the molecular understanding of vascular wall injury and healing, genetics of sudden cardiac death and molecular basis of coronary artery disease.? When not running CVPath, he performs interventional cardiology procedures at University of Maryland.